Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.079 | 0.2 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.03 |